Gentamicin-loaded bioresorbable films for prevention of bacterial infections associated with orthopedic implants

被引:80
作者
Aviv, Moran
Berdicevsky, Israela
Zilberman, Meital [1 ]
机构
[1] Tel Aviv Univ, Dept Biochem Engn, IL-69978 Tel Aviv, Israel
[2] Technion Israel Inst Technol, Dept Microbiol, IL-32000 Haifa, Israel
关键词
bioresorbable films; poly(lactic acid); poly(D; L-lactic-co-glycolic acid); gentamicin; controlled drug delivery;
D O I
10.1002/jbm.a.31184
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Adhesion of bacteria to biomaterials and the ability of many microorganisms to form biofilms on foreign bodies are well-established as major contributors to the pathogenesis of implant-associated infections. Treatment of bone infection remains problematic, due to the difficulty of systemically administered antibiotics to locally penetrate bone. The current research addresses this issue by focusing on the development and study of novel gentamicin-loaded bioresorbable films designed to serve as 'coatings" for fracture fixation devices and prevent implant-associated infections. Poly(L-lactic acid) and poly (D,L-4actic-co-glycolic acid) films containing gentamicin were developed through solution processing. The effects of polymer type, drug content, and processing conditions on the drug release profile were studied with respect to film morphology. The examined films generally exhibited a burst effect followed by a moderate approximately constant rate of release. The drug contents in the surrounding medium exceeded the required minimal effective concentration. Various gentamicin concentrations that were released from the films with time exhibited efficacy against bacterial species known to be involved in orthopedic infections. The developed systems can be applied on the surface of any metallic or polymeric fracture fixation device, and may therefore comprise a significant contribution to the field of orthopedic implants. (c) 2007 Wiley Periodicals.
引用
收藏
页码:10 / 19
页数:10
相关论文
共 24 条
[1]   In vitro-in vivo characterization of gentamicin bone implants [J].
Baro, M ;
Sánchez, E ;
Delgado, A ;
Perera, A ;
Évora, C .
JOURNAL OF CONTROLLED RELEASE, 2002, 83 (03) :353-364
[2]   RELEASE OF GENTAMICIN FROM ACRYLIC BONE-CEMENT [J].
BUNETEL, L ;
SEGUI, A ;
CORMIER, M ;
PERCHERON, E ;
LANGLAIS, F .
CLINICAL PHARMACOKINETICS, 1989, 17 (04) :291-297
[3]   Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology [J].
Gollwitzer, H ;
Ibrahim, K ;
Meyer, H ;
Mittelmeier, W ;
Busch, R ;
Stemberger, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (03) :585-591
[4]   In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis [J].
Gürsel, I ;
Korkusuz, F ;
Türesin, F ;
Alaeddinoglu, NG ;
Hasirci, V .
BIOMATERIALS, 2001, 22 (01) :73-80
[5]   Gene therapy in orthopaedic surgery [J].
Hannallah, D ;
Peterson, B ;
Lieberman, JR ;
Fu, FH ;
Huard, J .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (06) :1046-1061
[6]  
Huang YY, 2001, J MICROENCAPSUL, V18, P457
[7]   Carrier systems for the local delivery of antibiotics in bone infections [J].
Kanellakopoulou, K ;
Giamarellos-Bourboulis, EJ .
DRUGS, 2000, 59 (06) :1223-1232
[8]   Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats [J].
Lucke, M ;
Schmidmaier, G ;
Sadoni, S ;
Wildemann, B ;
Schiller, R ;
Haas, NP ;
Raschke, M .
BONE, 2003, 32 (05) :521-531
[9]  
*NAT COMM CLIN LAB, 1983, TENT STAND METH DIL
[10]  
Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO